South Africa’s Janse van Rensburg to miss rest of Rugby Championship
By David Ochieng Mbewa The Springboks’ chances of winning the Rugby Championship suffered a blow following the withdrawal of lock Nicolaas Janse van Rensburg from the squad due to personal reasons. Springboks coach Jacques Nienaber said the strict COVID-19 protocols to enter Australia, which includes a mandatory two-week quarantine, meant van Rensburg will definitely miss the
WHO: Only 2 African countries have reached the 40% COVID-19 vaccination target
By Grace Kuria The World Health Organization (WHO) has announced that only two African countries have reached COVID-19 vaccination target. Speaking during the COVID-19 briefing on vaccine equity, WHO’s Director General Dr. Tedros Adhanom said, WHO’s global targets are to support every country to vaccinate at least 40 percent of its population by the end of
Kenya seeks to lure more tourists amid recovery of global travel sector
By XINHUA Kenya is seeking to lure more visitors for the remainder of the year amid the recovery of the global travel sector, a government official said on Tuesday. Najib Balala, cabinet secretary, Ministry of Tourism and Wildlife told journalists in Nairobi that for the first six months of 2021, the country received 305,635 foreign travelers.
Merck Foundation CEO Champions “Fashion With Purpose” to Break Infertility Stigma
By News Desk Merck Foundation, the philanthropic arm of Merck KGaA Germany conducted an award ceremony to felicitate and celebrate the winners of ‘Merck Foundation More Than a Mother’ FASHION AWARDS 2020. The awards were announced in partnership with the African First Ladies, also the Ambassadors of Merck Foundation More Than a Mother. Senator, Dr. Rasha Kelej, CEO of Merck
No need for a vaccine third jab booster: study
By AFP Vaccines are effective enough at preventing severe cases of COVID-19 that there is no current need for the general population to be given third doses, according to a report in The Lancet published Monday. Some countries have started offering extra doses over fears about the much more contagious Delta variant, causing the World Health
Johnson & Johnson reports promising Ebola vaccine data
By Reuters Johnson & Johnson said on Monday its Ebola vaccine regimen demonstrated antibody immune responses in adults and children, citing data published in the Lancet Infectious Diseases journal. The two-dose regimen was well-tolerated and induced antibody responses to the Zaire ebolavirus species 21 days after the second dose in 98 percent of all participants, the